Dr. Amir Toussi, MD

Dr. Toussi practices at UPMC Passavant-McCandless in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Toussi's NPI, 1316353857, was assigned on July 4, 2014. Dr. Toussi graduated from University of Pittsburgh School of Medicine in 2014. Dr. Toussi holds Pennsylvania license MD467646.

Dr. Toussi's primary practice is UPMC Passavant-McCandless, at 9100 Babcock Boulevard, Pittsburgh, PA 15237 in Allegheny County. The practice phone is (412) 367-6700.

Dr. Toussi's primary practice is UPMC Passavant-McCandless in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Toussi is also affiliated with UPMC Presbyterian. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Toussi to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Toussi practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Toussi's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Toussi's licenses on file in 2 states: Pennsylvania and Minnesota.

CMS data shows 557 Medicare services from Dr. Toussi across 17 procedure codes in 2024, for 226 Medicare patients. Medicare paid $39,996 for them.

CMS counts 226 Medicare patients who saw Dr. Toussi in 2024. The largest group is 65 to 74, with 119 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Toussi's median patient age at 71, with 20% women.

In 2024, Dr. Toussi wrote 919 Medicare Part D claims for 259 patients. 97% of them were for generic drugs. CMS names the drug for 809 of them, across 13 drugs with 11 or more claims each, at $35,393 in total drug cost. In 2023, CMS named 699 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Toussi for performance year 2024, reported as part of a group. Dr. Toussi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Toussi as offering telehealth. CMS counts 14 procedures of prostate resection by Dr. Toussi, more than 69% of the clinicians it reports for that procedure.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Toussi, published from 2013 to 2023. 2019 was the busiest year, with 4. The most frequent topics are Kidney Neoplasms, Erectile Dysfunction and Penile Erection. Dr. Toussi has published most often in Urology. Dr. Toussi's most frequent co-authors are Stephen Anthony Boorjian, MD, Igor Frank, MD and Matthew K. Tollefson, MD.

Dmand AI links Dr. Toussi to 1 clinical trial. Conditions studied include Ureteral Neoplasms and Ureteral Diseases.

CMS Open Payments shows 12 general payments to Dr. Toussi from 6 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 88% of the total. Boston Scientific Corporation paid the most, $316.

Dr. Toussi graduated from University of Pittsburgh School of Medicine in 2014.